Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

The First Affiliated Hospital with Nanjing Medical University · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
diffuse-large-b-cell-lymphomana
Based on the modified R-MINE of mitoxantrone hydrochloride liposome, the corresponding targeted drug (X) was added according to the genotyping detected by second-generation gene sequencing (NGS) to explore the effectiveness and safety of R-MINE+X in the treatment of recurrent/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1007660
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive